Abraham Olufemi Asuku, PhD, earned his doctorate in neurophysiology in the Department of Physiology, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria. He earned his Bachelor of Science degree (B.Sc.) and Master’s degree (M.Sc.) from the same department. Dr. Asuku is a passionate neuroscientist and medical biotechnologist. He currently works with the National Biotechnology Research and Development Agency, Nigeria, as a chief scientific officer. His area of interest is on mitigation of neurotoxicity, neurodegenerative diseases, and neurodevelopmental disorders by phytochemicals, and also on the applications of nanotechnology for neurodegenerative diseases drug delivery. He is a member of the Neuroscience Society of Nigeria and the Physiological Society, United Kingdom. He is an award-winning researcher and has over 50 publications, including book chapters and research and review articles of good international repute with a high impact factor. He has served as a reviewer for many reputable journals. He has also presented seminars at many conferences, both locally and internationally. He was one of the invited guest speakers at the VII International Conference of Universidad Tecnica De Manabi, Ecuador, in 2023. Dr. Asuku is currently editing another book, Bioresources for Managing and Treating Dementia: Prospects and Challenges, to be published by CRC Press/Taylor & Francis Group. His long-term goal is to discover therapeutic targets and help create focused treatments for dementia. By bridging the gap between basic and translational neuroscience, he seeks to further knowledge of neuronal health and provide insights that may result in novel treatments.Ebele Joan Ajagun, MSc, is a distinguished clinical pharmacist and writer with a strong academic and professional background in pharmacology and therapeutics. She holds a bachelor’s degree in pharmacy and a master of science degree in pharmacology and therapeutics, equipping her with an in-depth understanding of drug actions, interactions and therapeutics applications; she is also a fellow of the West African Postgraduate College of Pharmacists (Clinical Pharmacy), a testament to her expertise, leadership and commitment to advancing clinical pharmacy practice across the region. With years of hands-on experience in patient care, research and academia, she brings a unique blend of scientific insight and human compassion to both her professional work and her writing. As an author, her work often explores themes related to health, healing and the human experience, aiming to educate, inspire and empower readers. Her writing reflects a passion for evidence-based practice and a deep respect for the power of storytelling in healthcare.Gbonjubola Oyinlola Ogungbangbe, BSc, is a budding neuroscientist and has worked as a electroencephalography technologist at the University of Ilorin Teaching Hospital, Nigeria. She graduated from the University of Ilorin, Nigeria with a Bachelor in Physiology with honors, significant research experiences in the field of clinical neuroscience with her undergraduate thesis focusing on the anti-oxidant and neurobehavioural effects of 6-gingerol rich extract of ginger on mecury chloride induced neurotoxicity in male Wistar rats. She is an academic writer and also a registered associated member (Provisional Clinical Physiologist) of the Professional Association of Practicing Clinical Physiologists in Nigeria. Her research interests include Neurodevelopmental disorders, Neurodegenerative diseases, Neuronal development, Epilepsy and Seizure disorders, as well as the neuroscience of Pain and Inflammation. She is also a volunteer for various NGOs, and a member and mentor of neuroscience organizations such as simply neuroscience and World women in Neuroscience. She is working towards earning her PhD in Neuroscience, and focusing on the effect of neuroinflammation on specific areas of the brain. She has a grounded knowledge of the concepts of psychology and various electrophysiological methods used in neuroscience, and her main goal is to expand the current knowledge of Alzheimer's disease.
